Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analogues

• Main Authors: Wolin EM (Author), Jarzab B (Author), Eriksson B (Author), Walter T (Author), Toumpanakis C (Author), Morse MA (Author), Tomassetti P (Author), Weber MM (Author), Fogelman DR (Author), Ramage J (Author), Poon D (Author), Gadbaw B (Author), Li J (Author), Pasieka JL (Author), Mahamat A (Author), Swahn F (Author), Newell-Price J (Author), Mansoor W (Author), Öberg K (Author)
• Format: Book
• Published: Dove Medical Press, 2015-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Edward M Wolin,1 Barbara Jarzab,2 Barbro Eriksson,3 Thomas Walter,4 Christos Toumpanakis,5 Michael A Morse,6 Paola Tomassetti,7 Matthias M Weber,8 David R Fogelman,9 John Ramage,10 Donald Poon,11 Brian Gadbaw,12 Jiang Li,12 Janice L Pasieka,13 Abakar Mahamat,14 Fredrik Swahn,15 John Newell-Price,16...